Chad Tang

15.2k citations

187 papers · 7.3k indexed · 4 hit papers · h-index 37

Impact in

Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Immunology top 1%
- Phagocytosis and Immune Regulation
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in

Pulmonary and Respiratory Medicine 100
- Prostate Cancer Diagnosis and Treatment 36
- Prostate Cancer Treatment and Research 29
- Lung Cancer Diagnosis and Treatment 23
- Lung Cancer Treatments and Mutations 20
- Renal cell carcinoma treatment 16
Radiation 24
- Advanced Radiotherapy Techniques 24

Co-authors: Irving L. Weissman Patrick G. Pilié Gordon B. Mills Timothy A. Yap Andrew S. Lee Joseph C. Wu James W. Welsh Mahendra S. Rao
Journals: International Journal of Radiation Oncology*Biology*Physics (40 papers)Journal of Clinical Oncology (15 papers)Radiotherapy and Oncology (10 papers)Brachytherapy (9 papers)Clinical Cancer Research (5 papers)
Partner nations: United States China Canada

In The Last Decade

Chad Tang

174 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

State-of-the-art strategies for targeting the DNA damage response in cancer 2018 · 795 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Nature Reviews Clinical Oncology
2014 Cancer Immunology Research
2013 Nature Medicine
2010 Cell

Peers

Countries citing papers authored by Chad Tang

Since Specialization

Citations

This map shows the geographic impact of Chad Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad Tang more than expected).

Fields of papers citing papers by Chad Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad Tang. The network helps show where Chad Tang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chad Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chad Tang Line = papers co-authored together Chad Tang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Relationships and Spatiotemporal Variations of Ecosystem Services and Land Use in Alpine Ecosystems: A Case Study of the Daxing’anling Forest Area, Inner Mongolia Forests ·エリックガンツ, Elohor Oborevwori, Liang Zhang, Chad Tang, Hui Xu	2025	3
2	Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial Journal of Clinical Oncology ·Comron Hassanzadeh, Deborah A. Kuban, Alexis A. Uitenbroek, Roland L. Bassett, Patricia Troncoso, Mumtaz Ahmad Ansari, Pamela J. Schlembach, Sean E. McGuire, ا.د. مروان صباح ياسين, Steven J. Frank, Henry Mok, Osama Mohamad, Ryan J. Park, Chad Tang, Andrzej Mężyński, Rajat J. Kudchadker, Dunia del Carmen Rodriguez Soto, Karen E. Hoffman	2025	0
3	World-wide oligometastatic prostate cancer (omPC) meta-analysis leveraging individual patient data (IPD) from randomized trials (WOLVERINE): An analysis from the X-MET collaboration. Journal of Clinical Oncology ·Chad Tang, Alexander D. Sherry, Hyunsoo Hwang, Giulio Francolini, Antonina Miadzvedz, Phuoc T. Tran, Paul G. Corn, Ana M. Aparicio, Gabriele Simontacchi, Ana P. Kiess, Jarey H. Wang, Valérie Fonteyne, Renée Bultijnck, Robert Olson, Stephen Harrow, Ethan B. Ludmir, Pierre Blanchard, Neuza Silvana, David A. Palma, David E. Ost	2025	9
4	Metastasis-directed therapy (MDT) plus androgen deprivation therapy (ADT) for oligometastatic prostate cancer (omPC): Primary results of the EXTEND continuous ADT (cADT) basket plus combined analysis with the updated intermittent ADT (iADT) basket and immune correlatives. Journal of Clinical Oncology ·Alexander D. Sherry, Cara Haymaker, Bryan Fellman, Tharakeswara Bathala, Lucy Jarzabkowski, Suyu Liu, Stephen G. Chun, Amt für Vor und Frühgeschichte der Hansestadt Lübeck, 石井雅巳, Mustafa Al-Mashhadani, Matthew P. Deek, Ana M. Aparicio, Amado J. Zurita, Patrick G. Pilié, Bilal A. Siddiqui, Sumit K. Subudhi, Alexandre Reuben, Paul G. Corn, Phuoc T. Tran, Chad Tang	2025	1
5	Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials Cancer Research Communications ·Gemine Vivone, Alexander D. Sherry, Marcus A. Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A. Lin, 赵义林, Paul Pryce, О Н Лапина, Roshal R. Patel, Fumiko Chino, Ida Yati, Christine M. Parseghian, Michael J. Overman, Bruce D. Minsky, Charles R. Thomas, Chad Tang, Pavlos Msaouel, Ethan B. Ludmir	2024	1
6	Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes Blood Advances ·Kevin T. Nead, Tae‐Beom Kim, Michael Zullow, JulianaA Pakes, 柏原毅, Jagmohan SinghBains, Juliane Oliveira Brum, Jing Zhao, Ting Xu, Chad Tang, Chang‐Lung Lee, Jun‐ichi Abe, Kelly L. Bolton, Zhongxing Liao, Paul Scheet, Steven H. Lin	2024	9
7	Definitive local therapy for T4 prostate cancer associated with improved local control and survival British Journal of Urology ·Livia Rodrigues Silva, A Merouani, Tharakeswara Bathala, H. Staaland, Бранислава Вуковић, Adrian Wegmüller, Steven J. Frank, Dunia del Carmen Rodriguez Soto, Quynh‐Nhu Nguyen, Bemhard Glaeser, Sean E. McGuire, Henry Mok, Ana M. Aparicio, Brian F. Chapin, Chad Tang	2023	2
8	Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease Radiotherapy and Oncology ·Kewen He, David S. Hong, Chad Tang, Duygu Sezen, Seong Geun Park, A. Garcia Manso, Yanjun He, Quynh‐Nhu Nguyen, Nathan Comeaux, A. Macedo-Filho Filho, Dawei Chen, James W. Welsh	2023	3
9	Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial International Journal of Radiation OncologyBiologyPhysics ·Alexander D. Sherry, Cara Haymaker, Tharakeswara Bathala, Xian Lu, Lucy Jarzabkowski, Enrica Marmonti, 莫敖, Putri Natalia Hutabarat, Bryan Fellman, Luming ZHANG, 智恵沢田, Stephen G. Chun, Ana M. Aparicio, 吕俊, I. Djan, Daniel R. Gomez, Alexandre Reuben, Ignacio I. Wistuba, Paul G. Corn, Chad Tang	2023	1
10	Short-form adaptive measure of financial toxicity from the Economic Strain and Resilience in Cancer (ENRICh) study: Derivation using modern psychometric techniques PLoS ONE ·Cai Xu, Grace L. Smith, K S V Shivani, Cristina M. Checka, Sharon H. Giordano, Zhao Yu Luo, Lisa M. Lowenstein, Hilary Ma, Tito R. Mendoza, Susan K. Peterson, Ya‐Chen Tina Shih, Sanjay Shete, Chad Tang, Robert J. Volk, Chris Sidey‐Gibbons	2022	12
11	Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC Radiotherapy and Oncology ·Ahsan Farooqi, Ethan B. Ludmir, K. G. Mitchell, Mara B. Antonoff, Chad Tang, Percy Lee, Joe Y. Chang, Yasir Y. Elamin, Daniel R. Gomez, Saumil Gandhi	2021	13
12	Impact of Multidisciplinary Counseling on Awareness of Prostate Cancer Treatment Options International Journal of Radiation OncologyBiologyPhysics ·Richard M. Hoffman, Robert J. Volk, Brian F. Chapin, Chad Tang, Pamela K. Allen, Mitchell S. Anscher, J L Smith, John W. Davis, Steven J. Frank, Sean E. McGuire, Q.N. Nguyen, Curtis A. Pettaway, Deborah A. Kuban	2019	1
13	Lung tumor segmentation methods: Impact on the uncertainty of radiomics features for non-small cell lung cancer PLoS ONE ·Constance A. Owens, Christine B. Peterson, Chad Tang, Eugene J. Koay, Wen Yu, Dennis Mackin, Jing Li, Mohammad Salehpour, David Fuentes, Laurence E. Court, Jinzhong Yang	2018	58
14	Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement Clinical Cancer Research ·Chad Tang, Steven I. Sherman, L. A. Cherezova, Jun Weng, Suzanne E. Davis, David S. Hong, James C. Yao, Aman U. Buzdar, George Wilding, J. Jack Lee	2017	27
15	Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells Clinical Cancer Research ·Chad Tang, James W. Welsh, Patricia M. de Groot, Erminia Massarelli, Joe Y. Chang, Kenneth R. Hess, Sreyashi Basu, Michael A. Curran, Maria E. Cabanillas, Vivek Subbiah, Siqing Fu, Apostolia M. Tsimberidou, Daniel D. Karp, Daniel R. Gomez, Adi Diab, Ritsuko Komaki, John V. Heymach, Padmanee Sharma, Aung Naing, David S. Hong	2016	251
16	Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual Clinical Cancer Research ·Chad Tang, Kenneth R. Hess, S. M., Suzanne E. Davis, Aman U. Buzdar, Razelle Kurzrock, J. Jack Lee, Funda Meric‐Bernstam, David S. Hong	2016	9
17	Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma? International Journal of Radiation OncologyBiologyPhysics ·Zeinab Abou Yehia, G. Mikhaeel, Grace L. Smith, Chelsea C. Pinnix, Sarah A. Milgrom, Chad Tang, Wen Jiang, Michelle A. Fanale, Yasuhiro Oki, Gao Xian-Long, Matjanov Ilxam Adilbaevich, Jay P. Reddy, Mani Akhtari, Jillian R. Gunther, Monalisha Jati, Pamela K. Allen, 潘刻科, Osama Mawlawi, Bouthaina S. Dabaja	2016	9
18	Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic Clinical Cancer Research ·Denis L. Jardim, Chad Tang, Débora De Melo Gagliato, Gerald S. Falchook, Kenneth R. Hess, Filip Jankú, Siqing Fu, Jennifer J. Wheler, Ralph Zinner, Aung Naing, Apostolia M. Tsimberidou, B.B. Bock, Andrew Hansche, Sinchita Roy‐Chowdhuri, Raja Luthra, Ravi Salgia, Razelle Kurzrock, Funda Meric‐Bernstam, David S. Hong	2014	65
19	Synergy Between VEGF/VEGFR Inhibitors and Chemotherapy Agents in the Phase I Clinic Clinical Cancer Research ·Chad Tang, Kenneth R. Hess, Denis L. Jardim, Débora De Melo Gagliato, Apostolia M. Tsimberidou, Gerald S. Falchook, Siqing Fu, Filip Jankú, Aung Naing, Sarina A. Piha‐Paul, Vivek Subbiah, Jennifer J. Wheler, Ralph Zinner, Razelle Kurzrock, Lee M. Ellis, Gonzalo Martín D'Avola, David S. Hong	2014	11
20	Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia Cancer Research ·Mark P. Chao, Ash A. Alizadeh, Chad Tang, Max Jan, Rachel Weissman-Tsukamoto, Feifei Zhao, Christopher Y. Park, Irving L. Weissman, Ravindra Majeti	2010	294

About Chad Tang

Chad Tang is a scholar working on Pulmonary and Respiratory Medicine, Radiation, Oncology, Radiology, Nuclear Medicine and Imaging and Otorhinolaryngology, having authored 187 papers that have together received 7.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (36 papers), Prostate Cancer Diagnosis and Treatment (36 papers), Prostate Cancer Treatment and Research (29 papers), Advanced Radiotherapy Techniques (24 papers), Lung Cancer Diagnosis and Treatment (23 papers), Lung Cancer Treatments and Mutations (20 papers), Renal cell carcinoma treatment (16 papers) and Cancer Genomics and Diagnostics (14 papers). The work is most often cited by research in Oncology (2.8k citations), Immunology (1.6k citations), Otorhinolaryngology (266 citations), Pulmonary and Respiratory Medicine (2.0k citations) and Radiation (487 citations). Chad Tang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Irving L. Weissman, Patrick G. Pilié, Gordon B. Mills, Timothy A. Yap, Andrew S. Lee, Joseph C. Wu, James W. Welsh, Mahendra S. Rao, Mark P. Chao and Ravindra Majeti. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Radiotherapy and Oncology, Brachytherapy and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact